Company

Phoenix Molecular Designs

As of the edition of 20 October 2026, Phoenix Molecular Designs runs 1 drug.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active1
Total1

Where its trials are

  • Cancer: 1 trials led
  • Skin and connective tissue: 1 trials led